155 related articles for article (PubMed ID: 31852699)
1. Pragmatic multicentre randomised controlled trial evaluating the impact of a routine molecular point-of-care 'test-and-treat' strategy for influenza in adults hospitalised with acute respiratory illness (FluPOC): trial protocol.
Beard K; Brendish N; Malachira A; Mills S; Chan C; Poole S; Clark T
BMJ Open; 2019 Dec; 9(12):e031674. PubMed ID: 31852699
[TBL] [Abstract][Full Text] [Related]
2. Clinical impact of a routine, molecular, point-of-care, test-and-treat strategy for influenza in adults admitted to hospital (FluPOC): a multicentre, open-label, randomised controlled trial.
Clark TW; Beard KR; Brendish NJ; Malachira AK; Mills S; Chan C; Poole S; Ewings S; Cortes N; Nyimbili E; Presland L
Lancet Respir Med; 2021 Apr; 9(4):419-429. PubMed ID: 33285143
[TBL] [Abstract][Full Text] [Related]
3. Molecular point-of-care testing for respiratory viruses versus routine clinical care in adults with acute respiratory illness presenting to secondary care: a pragmatic randomised controlled trial protocol (ResPOC).
Brendish NJ; Malachira AK; Clark TW
BMC Infect Dis; 2017 Feb; 17(1):128. PubMed ID: 28166743
[TBL] [Abstract][Full Text] [Related]
4. Randomised controlled trial and health economic evaluation of the impact of diagnostic testing for influenza, respiratory syncytial virus and Streptococcus pneumoniae infection on the management of acute admissions in the elderly and high-risk 18- to 64-year-olds.
Nicholson KG; Abrams KR; Batham S; Medina MJ; Warren FC; Barer M; Bermingham A; Clark TW; Latimer N; Fraser M; Perera N; Rajakumar K; Zambon M
Health Technol Assess; 2014 May; 18(36):1-274, vii-viii. PubMed ID: 24875092
[TBL] [Abstract][Full Text] [Related]
5. Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial.
Brendish NJ; Malachira AK; Armstrong L; Houghton R; Aitken S; Nyimbili E; Ewings S; Lillie PJ; Clark TW
Lancet Respir Med; 2017 May; 5(5):401-411. PubMed ID: 28392237
[TBL] [Abstract][Full Text] [Related]
6. Antivirals for influenza-Like Illness? A randomised Controlled trial of Clinical and Cost effectiveness in primary CarE (ALIC
Bongard E; van der Velden AW; Cook J; Saville B; Beutels P; Munck Aabenhus R; Brugman C; Chlabicz S; Coenen S; Colliers A; Davies M; De Paor M; De Sutter A; Francis NA; Glinz D; Godycki-Ćwirko M; Goossens H; Holmes J; Ieven M; de Jong M; Lindbaek M; Little P; Martinón-Torres F; Moragas A; Pauer J; Pfeiferová M; Radzeviciene-Jurgute R; Sundvall PD; Torres A; Touboul P; Varthalis D; Verheij T; Butler CC
BMJ Open; 2018 Jul; 8(7):e021032. PubMed ID: 30002007
[TBL] [Abstract][Full Text] [Related]
7. Impact of a PCR point of care test for influenza A/B on an acute medical unit in a large UK teaching hospital: results of an observational, pre and post intervention study.
Garvey MI; Wilkinson MAC; Bradley CW; Biggs M; Reddy-Kolanu V; Osman H; Carmalt S; Holden E
Antimicrob Resist Infect Control; 2019; 8():120. PubMed ID: 31346461
[TBL] [Abstract][Full Text] [Related]
8. Clinicians' attitude towards a placebo-controlled randomised clinical trial investigating the effect of neuraminidase inhibitors in adults hospitalised with influenza.
Bradbury N; Nguyen-Van-Tam J; Lim WS
BMC Health Serv Res; 2018 May; 18(1):311. PubMed ID: 29716584
[TBL] [Abstract][Full Text] [Related]
9. Systematic review of the impact of point-of-care testing for influenza on the outcomes of patients with acute respiratory tract infection.
Egilmezer E; Walker GJ; Bakthavathsalam P; Peterson JR; Gooding JJ; Rawlinson W; Stelzer-Braid S
Rev Med Virol; 2018 Sep; 28(5):e1995. PubMed ID: 30101552
[TBL] [Abstract][Full Text] [Related]
10. The impact of early neuraminidase inhibitor therapy on clinical outcomes in patients hospitalised with influenza A-related pneumonia: a multicenter, retrospective study.
Chen L; Han X; Li YL; Zhang C; Xing X
BMC Infect Dis; 2020 Aug; 20(1):628. PubMed ID: 32842994
[TBL] [Abstract][Full Text] [Related]
11. Utility of early influenza diagnosis through point-of-care testing in children presenting to an emergency department.
Li-Kim-Moy J; Dastouri F; Rashid H; Khandaker G; Kesson A; McCaskill M; Wood N; Jones C; Zurynski Y; Macartney K; Elliott EJ; Booy R
J Paediatr Child Health; 2016 Apr; 52(4):422-9. PubMed ID: 27145506
[TBL] [Abstract][Full Text] [Related]
12. Multiplex PCR point of care testing versus routine, laboratory-based testing in the treatment of adults with respiratory tract infections: a quasi-randomised study assessing impact on length of stay and antimicrobial use.
Andrews D; Chetty Y; Cooper BS; Virk M; Glass SK; Letters A; Kelly PA; Sudhanva M; Jeyaratnam D
BMC Infect Dis; 2017 Oct; 17(1):671. PubMed ID: 29017451
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of Chou-Ling-Dan granules in the treatment of seasonal influenza via combining Western and traditional Chinese medicine: protocol for a multicentre, randomised controlled clinical trial.
He J; Li Z; Huang W; Guan W; Ma H; Yang ZF; Wang X
BMJ Open; 2019 Apr; 9(4):e024800. PubMed ID: 30944133
[TBL] [Abstract][Full Text] [Related]
14. Point-of-Care Influenza Testing Impacts Clinical Decision, Patient Flow, and Length of Stay in Hospitalized Adults.
Fjelltveit EB; Cox RJ; Østensjø J; Blomberg B; Ebbesen MH; Langeland N; Mohn KGI
J Infect Dis; 2022 Aug; 226(1):97-108. PubMed ID: 33151320
[TBL] [Abstract][Full Text] [Related]
15. Point of care testing of Influenza A/B and RSV in an adult respiratory assessment unit is associated with improvement in isolation practices and reduction in hospital length of stay.
Berry L; Lansbury L; Gale L; Carroll AM; Lim WS
J Med Microbiol; 2020 May; 69(5):697-704. PubMed ID: 32250239
[No Abstract] [Full Text] [Related]
16. Randomised multicentre effectiveness trial of rapid syndromic testing by panel assay in children presenting to European emergency departments with acute respiratory infections-trial protocol for the ADEQUATE Paediatric trial.
ADEQUATE Paediatric Trial Group
BMJ Open; 2024 Apr; 14(4):e076338. PubMed ID: 38670622
[TBL] [Abstract][Full Text] [Related]
17. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
18. The AMBER care bundle for hospital inpatients with uncertain recovery nearing the end of life: the ImproveCare feasibility cluster RCT.
Koffman J; Yorganci E; Murtagh F; Yi D; Gao W; Barclay S; Pickles A; Higginson I; Johnson H; Wilson R; Bailey S; Ewart C; Evans C
Health Technol Assess; 2019 Oct; 23(55):1-150. PubMed ID: 31594555
[TBL] [Abstract][Full Text] [Related]
19. Implementation of influenza point-of-care testing and patient cohorting during a high-incidence season: a retrospective analysis of impact on infection prevention and control and clinical outcomes.
Youngs J; Marshall B; Farragher M; Whitney L; Glass S; Pope C; Planche T; Riley P; Carrington D
J Hosp Infect; 2019 Mar; 101(3):276-284. PubMed ID: 30471317
[TBL] [Abstract][Full Text] [Related]
20. Randomised placebo-controlled multicentre effectiveness trial of adjunct betamethasone therapy in hospitalised children with community-acquired pneumonia: a trial protocol for the KIDS-STEP trial.
Kohns Vasconcelos M; Meyer Sauteur PM; Santoro R; Coslovsky M; Lurà M; Keitel K; Wachinger T; Beglinger S; Heininger U; van den Anker J; Bielicki JA
BMJ Open; 2020 Dec; 10(12):e041937. PubMed ID: 33376176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
